Trial NCT00303862

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02686
Secondary IDs: 14018A 7111 CDR0000460237 N01CM62201 N01CM62209 NCI-2012-02686 NCI-7111 P30CA014599 UCCRC-NCI-7111

Last trial update was posted on 2014-05-21

MeSH Interventions

Cediranib

MeSH Conditions

Carcinoma Carcinoma, Renal Cell

Other Conditions

Clear Cell Renal Cell Carcinoma Recurrent Renal Cell Cancer Stage IV Renal Cell Cancer

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID